Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function (clinicaltrials.gov) - Mar 26, 2025 - P1 | N=24 | Recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Nephrology • Renal Disease
|